ArticleBMC pulmonary medicine2014

Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.

Guodong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.